Lynglip-M (10x15 T)
In stock
Description
Composition
Vidagliptin 50mg + Metformin 500 mg SR Tab
Lynglip-M Tablets combine Vildagliptin 50 mg and Metformin Hydrochloride 500 mg, providing an effective dual-action therapy for the management of Type 2 Diabetes Mellitus. This combination helps improve blood sugar control by enhancing insulin secretion, reducing glucose production in the liver, and improving the body's response to insulin.
Key Benefits
- Helps maintain healthy blood glucose levels.
- Improves insulin secretion in a glucose-dependent manner.
- Reduces excess glucose production by the liver.
- Enhances insulin sensitivity for better glucose utilization.
- Supports long-term glycemic control when combined with a healthy diet and regular exercise.
